In our previous study, we reported that new types of anti-glaucoma drugs, including an EP2 agonist, OMD, and the ROCK inhibitor, Rip, induced different effects from those of the PGs in 3D spheroids obtained from GO-related fibroblasts (GHOF) [11]. Here, OMD is linked to glaucoma.